Adicet Bio, Inc. (NASDAQ:ACET) Receives $7.50 Average Target Price from Brokerages
Shares of Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the five research firms that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average […]
